09:30 - 11:30 | SESSION 2. TRAINED IMMUNITY AND VACCINES Moderator: África Gonzalez Heterologous effects of vaccines on health. Christine Stabell - Benn. University of Southern Denmark, Denmark MV130 as a trained immunity-based vaccine: mechanism of action and clinical impact. Carlos del Fresno, Hospital La Paz Institute for Health Research, Spain MTBVAC entry into TB efficacy trials and exploration of non-specific effects compared to BCG. Carlos Martín. University of Zaragoza, Spain Protection of adapted vaccines to omicron: more certainties than doubts. Eva Polverino. University Hospital Vall d'Hebron, Spain |
11:30 - 12:00 | Coffee break |
12:00 - 14:30 | SESSION 3. DEVELOPMENT AND REGULATION OF INNATE IMMUNE CELLS Moderator: Carmen Camara Myeloid cell mediated linkage between local inflammation and tissue homeostasis Dietmar Zaiss. University of Regensburg, Germany. Post-COVID19 trained immunity. Steven Josefowicz. Cornell University, USA. Genetic and epigenetic characterization of tolerogenic DC-10 Silvia Gregori. San Raffaele Scientific Institute, Italy. Calcineurin/NFAT Signalling Regulates β-glucan Induced Trained Immunity David Sancho. Spanish National Cardiovascular Research Center (CNIC), Madrid, Spain. Development of Myeloid cells Florent Ginhoux. Gustave Roussy Hospital, Villejuif, France. |
14:30 - 15:30 | LUNCH BREAK |
15:30-17:30 | SESSION 4. TARGETING AND VISUALIZING THE INNATE IMMUNE SYSTEM Moderator: María González Targeting innate immunity to treat disease Willem Mulder. Eindhoven University of Technology, The Netherlands In vivo imaging of the immune system for health and disease assessment Zahi Fayad. Icahn School of Medicine at Mount Sinai, New York, USA Trained immunity in mycrobacterial infections Maziar Divangahi. McGill University, Canada Trained immunity: a memory for innate host defense Mihai Netea. Radboud University Medical Center, the Netherlands |
17:30 - 18:00 | COFFEE BREAK |
18:00 - 19:00 | CLOSING SESSION. INNATE IMMUNITY AND HEALTH Moderador: Mihai Netea Innate immunity in health and disease Akiko Iwasaki. Yale School of Medicine and Howard Hughes Medical Institute, USA Discovery of toll-like receptors Ruslan Medzhitov. Yale School of Medicine and Howard Hughes Medical Institute, USA |
19:00 - 20:00 | AWARD CEREMONY |